(Q39793833)

14 September 2017

Monte Carlo cross-validation analysis screens pathway cross-talk associated with Parkinson's disease (English)

1 reference

14 September 2017

Tianrong Li

1

1 reference

PubMed ID

27146810

14 September 2017

Weidong Tang

series ordinal

2

1 reference

PubMed ID

27146810

14 September 2017

Li Zhang

series ordinal

3

1 reference

14 September 2017

4 May 2016

1 reference

14 September 2017

Neurological Sciences

1 reference

14 September 2017

37

1 reference

14 September 2017

8

1 reference

14 September 2017

1327-1333

1 reference

https://scigraph.springernature.com/pub.10.1007/s10072-016-2595-9

14 September 2017

0 references

cites work

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Association between early-onset Parkinson's disease and mutations in the parkin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

CHIP: a quality-control E3 ligase collaborating with molecular chaperones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Pathway level analysis of gene expression using singular value decomposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Classification of microarray data using gene networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Analysis and correction of crosstalk effects in pathway analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Molecular markers of early Parkinson's disease based on gene expression in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

affy--analysis of Affymetrix GeneChip data at the probe level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Pathway-based expression profile for breast cancer diagnoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Cell membranes and apoptosis: role of cardiolipin, phosphatidylcholine, and anticancer lipid analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

EGG phosphatidylcholine combined with vitamin B12 improved memory impairment following lesioning of nucleus basalis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Phosphatidylcholine biosynthesis during neuronal differentiation and its role in cell fate determination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Phosphatidylcholine and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Anti-inflammatory effects of phosphatidylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Effects of lysophosphatidylcholine on beta-amyloid-induced neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

PPARs at the crossroads of lipid signaling and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Phospholipase A2, Hydroxyl Radicals, and Lipid Peroxidation in Transient Cerebral Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Peroxisome proliferator-activated receptors and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

PPARdelta is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Pesticides, microglial NOX2, and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

CD28/B7 system of T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Upstream and downstream of mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Translational control of long-lasting synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-016-2595-9

Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.

21 January 2018

1 reference

12 December 2020

Relationship of membrane phospholipid composition, lactosylceramide molecular species, and the specificity of CMP-N-acetylneuraminate:lactosylceramide alpha 2,3-sialyltransferase to the molecular species composition of GM3 ganglioside

1 reference

12 December 2020

B7-blocking agents, alone or in combination with cyclosporin A, induce antigen-specific anergy of human memory T cells.

1 reference

12 December 2020

Mitochondrial dysfunction in Parkinson's disease

1 reference

12 December 2020

10.1007/S10072-016-2595-9

Identifiers

DOI

1 reference

14 September 2017

1 reference

PubMed ID

27146810